Displaying 61 to 64 of 64 investments
| Company | Country | Notes | ||
|---|---|---|---|---|
|
VIA Pharmaceuticals Inc Drug development company targeting vascular inflammation. |
United States | N/A |
|
|
|
Vivaldi Biosciences Inc Developing novel genetically modified vaccines to protect against common seasonal influenza and emergent pandemic influenza. |
United States | N/A |
|
|
|
VNUS Medical Technologies Inc VNUS markets a minimally invasive medical device to treat venous disease, including venous reflux and vein valve incompetence. |
United States | N/A |
|
|
ZymoGenetics Inc Discovery, development and commercialization of therapeutic proteins for the prevention and treatment of human diseases. |
United States | N/A Active |